Alzheimer's hope: common seizure drug may boost brain function
NCT ID NCT03875638
First seen Apr 09, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study tested whether levetiracetam, a drug used for epilepsy, can reduce overactive brain signals and improve thinking in people with early Alzheimer's disease. 58 adults aged 50-90 with mild Alzheimer's or mild cognitive impairment took the drug or a placebo. Researchers measured brain activity and cognitive test scores to see if the drug helped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.